Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2023
  2. Published

    Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease

    Adrian, T., Hornum, Mads, Knop, Filip Krag, Christensen, Karl Bang, Almdal, Thomas Peter, Rossing, Peter, Lídaa, L. Í., Heinrich, N. S., Boer, V. O., Marsman, A., Petersen, E. T., Siebner, Hartwig Roman & Feldt-Rasmussen, Bo, 2023, In: Nephron. 147, 11, p. 673–684 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Adrian, T., Hornum, Mads, Knop, Filip Krag, Almdal, Thomas Peter, Rossing, Peter, Lida, L., Heinrich, N. S., Boer, V. O., Marsman, A., Petersen, E. T., Siebner, Hartwig Roman & Feldt-Rasmussen, Bo, 2023, In: Nephron. 147, 6, p. 317–328

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

    Agarwal, R., Pitt, B., Palmer, B. F., Kovesdy, C. P., Burgess, E., Filippatos, G., Małyszko, J., Ruilope, L. M., Rossignol, P., Rossing, Peter, Pecoits-Filho, R., Anker, S. D., Joseph, A., Lawatscheck, R., Wilson, D., Gebel, M. & Bakris, G. L., 2023, In: Clinical Kidney Journal. 16, 2, p. 293-302 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

    Agarwal, R., Ruilope, L. M., Ruiz-Hurtado, G., Haller, H., Schmieder, R. E., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Lambelet, M., Nowack, C., Kolkhof, P., Joseph, A. & Bakris, G. L., 2023, In: Journal of Hypertension. 41, 2, p. 295-302 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

    Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, Peter, Pitt, B., Filippatos, G., Anker, S. D., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Annals of Internal Medicine. 176, 12, p. 1606-1616 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

    Agarwal, R., Pitt, B., Rossing, Peter, Anker, S. D., Filippatos, G., Ruilope, L. M., Kovesdy, C. P., Tuttle, K., Vaduganathan, M., Wanner, C., Bansilal, S., Gebel, M., Joseph, A., Lawatscheck, R. & Bakris, G. L., 2023, In: JAMA Cardiology. 8, 8, p. 732-741 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies

    Bahrami, H. S. Z., Jørgensen, P. G., Hove, Jens Dahlgaard, Dixen, Ulrik, Biering-Sørensen, Tor, Rossing, Peter & Jensen, M. T., 2023, In: European Heart Journal Cardiovascular Imaging. 24, 11, p. 1555-1562 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes

    Bakris, G. L., Ruilope, L. M., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Fried, L., Roy-Chaudhury, P., Sarafidis, P., Ahlers, C., Brinker, M., Joseph, A., Lawatscheck, R., Agarwal, R. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney International. 103, 1, p. 196-206 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial

    Bartholdy, K. V., Johansen, N. D., Landler, N., Skaarup, K. G., Jensen, J., Bressendorff, I., Schou, Morten, Christensen, J., Feldt-Rasmussen, Bo, Vaduganathan, M., Solomon, S., Haynes, R., Persson, F., Rossing, Peter, Køber, Lars Valeur, Zannad, F., Hansen, Ditte & Biering-Sørensen, Tor, 2023, In: Kidney360. 4, 2, p. 143-149 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

    Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Diabetes Care. 46, 3, p. 602-607 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 12937790